BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30694790)

  • 1. National Trends in Multimodality Therapy for Locally Advanced Gastric Cancer.
    Sada YH; Smaglo BG; Tran Cao HS; Mok H; Musher BL; Massarweh NN
    J Surg Res; 2019 May; 237():41-49. PubMed ID: 30694790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Nodal Response After Preoperative Treatment of Gastric Adenocarcinoma.
    Sada YH; Smaglo BG; Tan JC; Tran Cao HS; Musher BL; Massarweh NN
    J Natl Compr Canc Netw; 2019 Feb; 17(2):161-168. PubMed ID: 30787129
    [No Abstract]   [Full Text] [Related]  

  • 3. Adoption of evidence-based novel therapies in the treatment of gastric cancer: A national observational study.
    Mokdad AA; Ali A; Yopp AC; Polanco PM; Nassour I; Mansour JC; Choti MA; Minter RM; Wang SC; Porembka MR
    Cancer; 2018 Mar; 124(6):1122-1131. PubMed ID: 29211302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment approach, hospital practice patterns, and receipt of multimodality therapy as measures of quality for locally advanced gastric cancer.
    Portuondo JI; Tran Cao HS; da Costa WL; Sada YH; Harris AHS; Massarweh NN
    J Surg Oncol; 2021 May; 123(8):1724-1735. PubMed ID: 33721353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodality Treatment of T4 Gastric Cancer in the United States: Utilization Trends and Impact on Survival.
    Lowenfeld L; Datta J; Lewis RS; McMillan MT; Mamtani R; Damjanov N; Chandrasekhara V; Karakousis GC; Drebin JA; Fraker DL; Roses RE
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S863-72. PubMed ID: 26100818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of lymph node positivity in treatment planning for early stage pancreatic cancer.
    Tran Cao HS; Zhang Q; Sada YH; Silberfein EJ; Hsu C; Van Buren G; Chai C; Katz MHG; Fisher WE; Massarweh NN
    Surgery; 2017 Sep; 162(3):557-567. PubMed ID: 28666686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor downstaging after neoadjuvant chemotherapy determines survival after surgery for gastric adenocarcinoma.
    Levenson G; Voron T; Paye F; Balladur P; Debove C; Chafai N; De Dios AG; Lefevre JH; Parc Y
    Surgery; 2021 Dec; 170(6):1711-1717. PubMed ID: 34561115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodality Therapy Improves Survival in Resected Early Stage Gastric Cancer in the United States.
    Datta J; McMillan MT; Ruffolo L; Lowenfeld L; Mamtani R; Plastaras JP; Dempsey DT; Karakousis GC; Drebin JA; Fraker DL; Roses RE
    Ann Surg Oncol; 2016 Sep; 23(9):2936-45. PubMed ID: 27090793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of Lymph Node Staging on Selection of Adjuvant Therapy for Gastric Cancer in the United States: A Propensity Score-matched Analysis.
    Datta J; McMillan MT; Ecker BL; Karakousis GC; Mamtani R; Plastaras JP; Giantonio BJ; Drebin JA; Dempsey DT; Fraker DL; Roses RE
    Ann Surg; 2016 Feb; 263(2):298-305. PubMed ID: 26135687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective validation study to diagnose serosal invasion and nodal metastases of gastric cancer by multidetector-row CT.
    Hasegawa S; Yoshikawa T; Shirai J; Fujikawa H; Cho H; Doiuchi T; Yoshida T; Sato T; Oshima T; Yukawa N; Rino Y; Masuda M; Tsuburaya A
    Ann Surg Oncol; 2013 Jun; 20(6):2016-22. PubMed ID: 23266583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Gastric Resection in the Establishment of a Comprehensive Oncologic Robotic Program.
    Balbona J; Chen L; Malafa MP; Hodul PJ; Dineen SP; Mehta R; Mhaskar RS; Pimiento JM
    J Surg Res; 2020 Aug; 252():30-36. PubMed ID: 32222591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy for gastric adenocarcinoma in Japan.
    Kodera Y
    Surg Today; 2017 Aug; 47(8):899-907. PubMed ID: 28247105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.
    Cats A; Jansen EPM; van Grieken NCT; Sikorska K; Lind P; Nordsmark M; Meershoek-Klein Kranenbarg E; Boot H; Trip AK; Swellengrebel HAM; van Laarhoven HWM; Putter H; van Sandick JW; van Berge Henegouwen MI; Hartgrink HH; van Tinteren H; van de Velde CJH; Verheij M;
    Lancet Oncol; 2018 May; 19(5):616-628. PubMed ID: 29650363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a role for surgery with adequate nodal evaluation alone in gastric adenocarcinoma?
    Dudeja V; Habermann EB; Abraham A; Zhong W; Parsons HM; Tseng JF; Al-Refaie WB
    J Gastrointest Surg; 2012 Feb; 16(2):238-46; discussion 246-7. PubMed ID: 22089951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization patterns and temporal trends of internal mammary nodal irradiation at a tertiary cancer center.
    Misra S; Lee G; Maganti M; Koch CA
    Breast Cancer Res Treat; 2020 Jul; 182(2):367-379. PubMed ID: 32474745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment trends and predictors of adjuvant and neoadjuvant therapy for gastric adenocarcinoma in the United States.
    Sherman KL; Merkow RP; Bilimoria KY; Wang CE; Mulcahy MF; Benson AB; Bentrem DJ
    Ann Surg Oncol; 2013 Feb; 20(2):362-70. PubMed ID: 22890592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of D2 gastrectomy in gastric cancer with clinical para-aortic lymph node metastasis.
    Zheng XH; Zhang W; Yang L; Du CX; Li N; Xing GS; Tian YT; Xie YB
    World J Gastroenterol; 2019 May; 25(19):2338-2353. PubMed ID: 31148905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using a Lymph Node Count Metric to Identify Underperforming Hospitals After Rectal Cancer Surgery.
    Raoof M; Zafar SN; Ituarte PHG; Krouse RS; Melstrom K
    J Surg Res; 2019 Apr; 236():216-223. PubMed ID: 30694758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mediastinal Nodal Involvement After Neoadjuvant Chemoradiation for Siewert II/III Adenocarcinoma.
    Mitchell KG; Ikoma N; Nelson DB; Maru DM; Erasmus JJ; Weston BR; Vaporciyan AA; Antonoff MB; Mehran RJ; Rice DC; Roth JA; Swisher SG; Sepesi B; Walsh GL; Correa AM; Das P; Blum MA; Badgwell BD; Hofstetter WL
    Ann Thorac Surg; 2019 Sep; 108(3):845-851. PubMed ID: 31102632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validating the prognostic and discriminating value of the TNM-classification for gastric cancer - a critical appraisal.
    Röcken C; Behrens HM
    Eur J Cancer; 2015 Mar; 51(5):577-86. PubMed ID: 25682192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.